AR242986A1 - Un metodo de reduccion de la heterogeneidad de anticuerpos secretados por celulas productoras de anticuerpo. - Google Patents

Un metodo de reduccion de la heterogeneidad de anticuerpos secretados por celulas productoras de anticuerpo.

Info

Publication number
AR242986A1
AR242986A1 AR89310004A AR31000489A AR242986A1 AR 242986 A1 AR242986 A1 AR 242986A1 AR 89310004 A AR89310004 A AR 89310004A AR 31000489 A AR31000489 A AR 31000489A AR 242986 A1 AR242986 A1 AR 242986A1
Authority
AR
Argentina
Prior art keywords
antibodies
cells
reducing
heterogeneous nature
secreted
Prior art date
Application number
AR89310004A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/364,056 external-priority patent/US5126250A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of AR242986A1 publication Critical patent/AR242986A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AR89310004A 1988-09-28 1989-09-26 Un metodo de reduccion de la heterogeneidad de anticuerpos secretados por celulas productoras de anticuerpo. AR242986A1 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25078788A 1988-09-28 1988-09-28
US25078688A 1988-09-28 1988-09-28
US25078888A 1988-09-28 1988-09-28
US07/364,056 US5126250A (en) 1988-09-28 1989-06-09 Method for the reduction of heterogeneity of monoclonal antibodies
CA000613379A CA1332367C (en) 1988-09-28 1989-09-26 Method for the reduction of heterogeneity of monoclonal antibodies

Publications (1)

Publication Number Publication Date
AR242986A1 true AR242986A1 (es) 1993-06-30

Family

ID=27508376

Family Applications (1)

Application Number Title Priority Date Filing Date
AR89310004A AR242986A1 (es) 1988-09-28 1989-09-26 Un metodo de reduccion de la heterogeneidad de anticuerpos secretados por celulas productoras de anticuerpo.

Country Status (17)

Country Link
EP (1) EP0361902B1 (es)
JP (1) JP2925181B2 (es)
CN (1) CN1041392A (es)
AR (1) AR242986A1 (es)
AT (1) ATE101876T1 (es)
AU (1) AU615576B2 (es)
BG (1) BG60017B2 (es)
CA (1) CA1332367C (es)
DE (1) DE68913251T2 (es)
DK (1) DK475389A (es)
ES (1) ES2049332T3 (es)
IE (1) IE63562B1 (es)
IL (1) IL91778A (es)
MX (1) MX170441B (es)
NZ (1) NZ230786A (es)
PL (1) PL162260B1 (es)
RO (1) RO105652B1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11046784B2 (en) 2006-03-31 2021-06-29 Chugai Seiyaku Kabushiki Kaisha Methods for controlling blood pharmacokinetics of antibodies
EP1878747A1 (en) 2006-07-11 2008-01-16 greenovation Biotech GmbH Glyco-engineered antibodies
EP2031064A1 (de) * 2007-08-29 2009-03-04 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Steigerung von Proteintitern
MX369784B (es) 2007-09-26 2019-11-21 Chugai Pharmaceutical Co Ltd Metodo de modificacion del punto isoelectrico de anticuerpos mediante la sustitucion de aminoacidos en region de determinacion de complementariedad (cdr).
PH12018501459A1 (en) 2007-09-26 2019-11-11 Chugai Pharmaceutical Co Ltd Modified antibody constant region
DK2708559T3 (en) 2008-04-11 2018-06-14 Chugai Pharmaceutical Co Ltd Antigen-binding molecule capable of repeatedly binding two or more antigen molecules
TWI440469B (zh) * 2008-09-26 2014-06-11 Chugai Pharmaceutical Co Ltd Improved antibody molecules
JP5717624B2 (ja) 2009-03-19 2015-05-13 中外製薬株式会社 抗体定常領域改変体
JP5787446B2 (ja) 2009-03-19 2015-09-30 中外製薬株式会社 抗体定常領域改変体
CN108715614A (zh) 2010-11-30 2018-10-30 中外制药株式会社 与多分子的抗原重复结合的抗原结合分子
EP2660328A4 (en) * 2010-12-28 2016-07-13 Chugai Pharmaceutical Co Ltd ANIMAL CELL CULTURE METHOD
PL2970512T3 (pl) * 2013-03-12 2019-03-29 Biocon Limited Immunomodulujące białka fuzyjne i sposoby ich otrzymywania
US10782290B2 (en) 2013-06-11 2020-09-22 National Center Of Neurology And Psychiatry Method for predicting post-therapy prognosis of relapsing-remitting multiple sclerosis (RRMS) patient, and method for determining applicability of novel therapy
TWI805046B (zh) 2015-02-27 2023-06-11 日商中外製藥股份有限公司 Il-6受體抗體用於製備醫藥組成物的用途
PL3299810T3 (pl) 2015-05-19 2021-12-13 National Center Of Neurology And Psychiatry Sposób określania zastosowania nowej terapii u pacjentów ze stwardnieniem rozsianym (sm)
JP6976343B2 (ja) * 2016-10-17 2021-12-08 エンゼン・バイオサイエンシズ・リミテッドEnzene Biosciences Limited 治療用タンパク質の不均質性を低減するための連続的方法
US11851486B2 (en) 2017-05-02 2023-12-26 National Center Of Neurology And Psychiatry Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils
KR20200074160A (ko) 2017-10-20 2020-06-24 가꼬우호우징 효고 이카다이가쿠 항il-6 수용체 항체를 함유하는 수술 후의 유착을 억제하기 위한 의약 조성물

Also Published As

Publication number Publication date
AU615576B2 (en) 1991-10-03
AU4234389A (en) 1990-04-05
DE68913251D1 (de) 1994-03-31
ES2049332T3 (es) 1994-04-16
IE63562B1 (en) 1995-05-17
EP0361902A2 (en) 1990-04-04
RO105652B1 (ro) 1992-11-30
JPH02163096A (ja) 1990-06-22
NZ230786A (en) 1991-11-26
ATE101876T1 (de) 1994-03-15
DK475389A (da) 1990-03-29
DK475389D0 (da) 1989-09-27
CN1041392A (zh) 1990-04-18
CA1332367C (en) 1994-10-11
DE68913251T2 (de) 1994-06-23
BG60017B2 (en) 1993-06-30
IL91778A (en) 1994-10-07
MX170441B (es) 1993-08-23
EP0361902B1 (en) 1994-02-23
PL162260B1 (pl) 1993-09-30
EP0361902A3 (en) 1990-08-16
IE893094L (en) 1990-03-28
JP2925181B2 (ja) 1999-07-28

Similar Documents

Publication Publication Date Title
AR242986A1 (es) Un metodo de reduccion de la heterogeneidad de anticuerpos secretados por celulas productoras de anticuerpo.
GR3003648T3 (en) Method for producing composite cheeses.
HK147494A (en) Method for producing at least two.layered articles
YU212784A (en) Process for producing substituted aminocyclo-butene-3,4-diones
AU1010888A (en) Method for producing roux
GB2225137B (en) Method for extending the life of a plant.
PT79518A (en) Method for producing fibrinolytic agents by yeast
DE3565977D1 (en) A method for producing compounds having a double bond at the terminal
AU573694B2 (en) Method for producing high-strength inorganic cement
AR242264A1 (es) Metodo para la sintesis enzimatica de peptidos.
GB2166357B (en) A method for attaching an elctrode
SG50680A1 (en) Method for the production of monoclonal antibodies utilizing a germfree animal
AU1229983A (en) Method for the production of a fuel from waste
AU3210784A (en) Method for forming structures
EP0261066A3 (en) An improved method for producing composite structures
ZA876985B (en) A method for producing cellular pvc-plastic
IL73234A0 (en) A novel process for producing a cephalosporin,an intermediate for the cephalosporin,and a process for producing the intermediate
DE3568339D1 (en) Process for producing melting-anisotropic, copolymerized polyester
EP0224116A3 (en) A method for producing cycloalkanols
ZA891160B (en) Novel photoactive compounds,processes for their production and intermediates therefor
AU5678890A (en) A method for the activation of t cells
EP0233050A3 (en) Method for producing l-sorbose
EP0219117A3 (en) A method for producing alpha,alpha-dimethyl-delta-valerolactone
HU9300661D0 (en) Method for producing 3-(hydroxi-methyl)-1-propargyl-imidazolidine-2,4-dione
PL266755A1 (en) Method for manufacturing 6-amine-1,2-dihydro-1-hydroxy-2-amine-4-piperidinepyrimidine